ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA

Clinical trials for ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Major trial tests new drug combo for aggressive childhood cancers

Disease control Ongoing

This large, late-stage trial is comparing two chemotherapy programs for children and young adults newly diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LLy). One group receives the standard, intensive chemotherapy regimen. The other …

Matched conditions: ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA

Get alerted when new ANN ARBOR STAGE IV CHILDHOOD LYMPHOBLASTIC LYMPHOMA trials appear

Major trial tests new drug combo for aggressive childhood cancers